Eriko Matsuda,Yuki Obama,Ken-ichiro Kosai
Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte
growth factor gene therapyfor type 1 diabetes in mice.
Life Science. 268:119014. 2020
doi: 10.1016/j.lfs.2020.119014.
Shinsuke Suzuki,Hiroki Kofune,Kimiharu Uozumi,Makoto,Yoshimitsu,
Naomichi Arima,Kenji Ishitsuka,Shin-ichi Ueno, Ken-ichiro Kosai
A survivin-responsive, conditionally replicating adenovirus induces potent
cytocidal effects in adult T-cell leukemia/lymphoma.
BMC Cancer.19(1):516. 2019
doi: 10.1186/s12885-019-5730-1
Kanako Ide, Kaoru Mitsui, Rie Irie, Yohei Matsushita, Nobuhiro Ijichi, Soichiro
Toyodome, Ken-ichiro Kosai
A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic
Cells from Pluripotent Stem Cells.
Stem Cells.36:230-239. 2018
（# selected for the first FEATURED ARTICLE in “A Preview of Featured Article” in this issue）
（# selected for the first FEATURED ARTICLE in “A Preview of Selected Article” in this issue）
（# This article also appears in: Best of Japan）
Subcategories
業績
論文掲載「Translational Research」川上広高、伊地知暢広、小濵祐行、松田恵理子、三井薫、西川路侑耶、渡邉真希、永野聡、谷口昂、小宮節朗、小戝健一郎
『An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy』がTransl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.に掲載されました。
Transl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.
